Alliancebernstein L.P. Adds $17M in Bath & Body Works, Inc. ($BBWI)

Alliancebernstein L.P. has increased its stake in Bath & Body Works, Inc. (NYSE:BBWI) by 14.4%, according to its latest 13F filing with the SEC. The fund added 722,109 shares during the reporting period, bringing its total to 5,746,319 shares valued at approximately $125.3 million.

What Changed in Alliancebernstein's Bath & Body Works Position

Alliancebernstein L.P. grew its position in Bath & Body Works from 5,024,210 shares to 5,746,319 shares, a 14.4% increase. This boost in shares reflects a significant vote of confidence, with the total value of the holdings now standing at $125.3 million.

Other Institutional Activity in Bath & Body Works

Several other institutional investors adjusted their holdings in Bath & Body Works. FMR LLC increased its position by 3,944,735 shares, ending with 20,888,799 shares valued at about $390 million, a 23.3% increase. BlackRock, Inc. reduced its holdings by 1,826,464 shares, bringing its total to 19,322,372 shares worth $360.7 million, marking an 8.6% decrease. Vanguard Portfolio Management LLC opened a new position with 15,021,767 shares valued at $280.5 million. Meanwhile, AQR Capital Management LLC trimmed its stake by 405,215 shares, holding 11,040,713 shares valued at $206.1 million, a 3.5% decrease.

Bath & Body Works, Inc. Stock Up 20.3%

Shares of NYSE:BBWI traded near $21.81 on Thursday. Bath & Body Works has a market cap of approximately $3.96 billion, a P/E ratio of 5.58, and a forward P/E of 6.85. The stock's 52-week range is between $14.28 and $33.96. Its 50-day moving average is $18.81, and the 200-day moving average is $21.55. The company maintains a current ratio of 1.38 and a quick ratio of 0.67.

Recent Earnings

Bath & Body Works reported revenue of $7.24 billion with a slight decline in growth at -3.2%. The net margin stands at 10%, and the company reported an EPS of $3.52. The next earnings release is expected on August 27, 2026.

Dividend

Bath & Body Works offers an annual dividend rate of $0.80, yielding 3.89%. The dividend payout ratio is 22.7%, providing a consistent return to shareholders.

Insider Buying and Selling at Bath & Body Works, Inc.

In June 2026, several insiders made notable purchases. Interim CFO Tom Javitch acquired 10,309 shares, while Alessandro Bogliolo, Juan Rajlin, Sarah Nash, Francis Hondal, and Lucy Brady each bought 7,970 shares. These transactions were not part of any pre-planned trading programs.

Analysts Set New Price Targets

On June 23, 2026, Wells Fargo maintained a 'buy' rating with a price target of $26. On May 28, 2026, Telsey Advisory Group, TD Cowen, and Barclays maintained their ratings, with targets ranging from $22 to $25. Goldman Sachs and UBS held 'hold' ratings with targets of $23 and $19, respectively. The consensus among 14 analysts sets the mean price target at $25.57.

About Bath & Body Works, Inc.

Bath & Body Works, Inc., based in Columbus, Ohio, is a leading specialty retailer in the consumer cyclical sector. It offers a wide range of personal care and home fragrance products, including candles, mists, and lotions, through retail and e-commerce channels in the U.S. and Canada, as well as international franchise operations. The company, led by CEO Daniel Heaf, employs over 9,000 people.

Bottom Line

Alliancebernstein's increased stake in Bath & Body Works highlights its confidence in the company's potential. Investors often track such filings to gauge institutional sentiment, though it's important to note that 13F filings are historical and may not reflect current positions. Bath & Body Works continues to attract attention with its diverse product offerings and solid market presence.